- Home
- CRDL vs ALTO Comparison
CRDL vs ALTO Comparison
Compare CRDL & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- ALTO
- Stock Information
- Founded
- CRDL 2017
- ALTO 2003
- Country
- CRDL Canada
- ALTO United States
- Employees
- CRDL N/A
- ALTO N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- ALTO Major Chemicals
- Sector
- CRDL Health Care
- ALTO Industrials
- Exchange
- CRDL Nasdaq
- ALTO Nasdaq
- Market Cap
- CRDL 126.5M
- ALTO 95.7M
- IPO Year
- CRDL N/A
- ALTO N/A
- Fundamental
- Price
- CRDL $1.48
- ALTO $1.04
- Analyst Decision
- CRDL Strong Buy
- ALTO Strong Buy
- Analyst Count
- CRDL 2
- ALTO 1
- Target Price
- CRDL $9.00
- ALTO $5.50
- AVG Volume (30 Days)
- CRDL 365.4K
- ALTO 187.1K
- Earning Date
- CRDL 08-11-2025
- ALTO 08-06-2025
- Dividend Yield
- CRDL N/A
- ALTO N/A
- EPS Growth
- CRDL N/A
- ALTO N/A
- EPS
- CRDL N/A
- ALTO N/A
- Revenue
- CRDL N/A
- ALTO $951,169,000.00
- Revenue This Year
- CRDL N/A
- ALTO N/A
- Revenue Next Year
- CRDL N/A
- ALTO $7.68
- P/E Ratio
- CRDL N/A
- ALTO N/A
- Revenue Growth
- CRDL N/A
- ALTO N/A
- 52 Week Low
- CRDL $0.77
- ALTO $0.76
- 52 Week High
- CRDL $2.63
- ALTO $2.05
- Technical
- Relative Strength Index (RSI)
- CRDL 57.55
- ALTO 34.54
- Support Level
- CRDL $1.36
- ALTO $1.13
- Resistance Level
- CRDL $1.59
- ALTO $1.28
- Average True Range (ATR)
- CRDL 0.11
- ALTO 0.06
- MACD
- CRDL 0.02
- ALTO -0.02
- Stochastic Oscillator
- CRDL 75.56
- ALTO 3.96
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.